Quantitative Multimodal Fluorescence and Bioluminescence Tomography with the MILabs OI-CT System

Quantitative Multimodal Fluorescence and Bioluminescence Tomography with the MILabs OI-CT System

by Dr. Felix Gremse, RWTH Aachen University and Gremse IT

Hybrid fluorescence tomography and x-ray computed tomography (FLT-CT) provided by the MILabs OI-CT system allows non-invasive longitudinal volumetric assessment of fluorescent probes in mice in vivo. This talk demonstrates that FLT-CT can be used to quantitatively determine the biodistribution NIRF-labeled probes. It also demonstrates the functionality for multimodal bioluminescence tomography (BLT-CT) which uses multispectral images to identify deep luminescent sources such as luciferase-expressing tumors and metastases.

Took place: August, 2020 (at vEMIM)


You may also like

Bart Cornelissen imaging DNA damage webinar thumbnail
Each DNA damage repair pathway leads to the recruitment, upregulation, or activation of specific proteins within the nucleus, which, in some cases, can represent attractive targets for molecular imaging.
Fabian Kiessling webinar thumbnail
For a detailed biodistribution analysis, PET and SPECT are usually preferred as they are more accurate and quantitative, so the question is, can optical imaging become a complementary tool for pre-clinical biodistribution analysis.
webinar thumnail Marko Rosenholm
Marko Rosenholm presents some of the findings and results regarding dynamic SPECT/CT imaging of a glymphatic system they have acquired with the MILabs VECTor/CT system.
Scroll to Top